Draupnir Bio raised €12M in a Seed round in Jul 2024. The company is based in Copenhagen, Denmark. Investors in the round: Export and Investment Fund of Denmark (EIFO), Gilde Healthcare Partners, Inkef Capital and 2 others. Data as of 6 Aug 2026.
Reported in EUR — no conversion. €12M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.